Long-term treatment of established osteoporosis with intranasal calcitonin.

作者: Kirsten Overgaard , Claus Christiansen

DOI: 10.1007/BF02555091

关键词:

摘要: We examined the long-term effects of intranasal administration salmon calcitonin on bone and calcium metabolism in women with established osteoporosis (forearm fracture). Over a period 5 years, 14 received discontinuous (200 IU) plus (500 mg) daily for 3 years or 4 years. To allow assessment optimum duration therapy, patients whom treatment had been shorter intervals were also included. At end first 2 group receiving placebo lost significantly more from their spines forearms than year (P<0.01). In who completed further calcitonin, mineral contents increased continually. Bone loss forearm was arrested 1 year. Treatment lasting about prevented both areas. resulted net gains spinal but no benefits relation to forearms. Biochemical parameters turnover (serum alkaline phosphatase levels, plasma Gla protein fasting urinary hydroxy-proline/creatinine levels) exhibited similar declines irrespective treatment. It is concluded that longterm produced response achieved using therapy. The ratio between periods without 1∶2 2∶3.

参考文章(16)
J. Borg, C. Christiansen, A. Gotfredsen, L. Nilas, Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss The Journal of Nuclear Medicine. ,vol. 26, pp. 1257- 1262 ,(1985)
K. OVERGAARD, B. J. RIIS, C. CHRISTIANSEN, J. PØADENPHANT, J. S. JOHANSEN, NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS Clinical Endocrinology. ,vol. 30, pp. 435- 442 ,(1989) , 10.1111/J.1365-2265.1989.TB00443.X
Z. Bouizar, W. H. Rostene, G. Milhaud, Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 5125- 5128 ,(1987) , 10.1073/PNAS.84.15.5125
Thomas Hedlund, Anders Hulth, Olof Johnell, Early effects of parathormone and calcitonin on the number of osteoclasts and on serum-calcium in rats. Acta Orthopaedica Scandinavica. ,vol. 54, pp. 802- 804 ,(1983) , 10.3109/17453678308992912
R.L. Prince, R.I. Price, S. Ho, Forearm bone loss in hemiplegia: a model for the study of immobilization osteoporosis. Journal of Bone and Mineral Research. ,vol. 3, pp. 305- 310 ,(2009) , 10.1002/JBMR.5650030309
Helen E. Gruber, Joel L. Ivey, David J. Baylink, Meredith Matthews, Wil B. Nelp, Karen Sisom, Charles H. Chesnut, Long-term calcitonin therapy in postmenopausal osteoporosis Metabolism-clinical and Experimental. ,vol. 33, pp. 295- 303 ,(1984) , 10.1016/0026-0495(84)90187-2
J N Matthews, D G Altman, M J Campbell, P Royston, Analysis of serial measurements in medical research. BMJ. ,vol. 300, pp. 230- 235 ,(1990) , 10.1136/BMJ.300.6719.230
Kirsten Overgaard, Marc Allan Hansen, Vivi-Ann Herss Nielsen, Bente Juel Riis, Clause Christiansen, None, Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment The American Journal of Medicine. ,vol. 89, pp. 1- 6 ,(1990) , 10.1016/0002-9343(90)90089-V
M. Hörder, R. Keiding, W. Gerhardt Denmark, J. H. Strömme, E. Pitkänen, J. Waldenström, L. Westlund, R. Tenhunen, Liv Theodorsen, N. Tryding, Recommended Methods for the Determination of Four Enzymes in Blood Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 33, pp. 291- 306 ,(1974) , 10.1080/00365517409082499
G. F. Mazzuoli, M. Passeri, C. Gennari, S. Minisola, R. Antonelli, C. Valtorta, E. Palummeri, G. F. Cervellin, S. Gonnelli, G. Francini, Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcified Tissue International. ,vol. 38, pp. 3- 8 ,(1986) , 10.1007/BF02556587